GlycoFi is a company headquartered in the United States.
GlycoFi develops technologies to optimize and engineer glycosylation patterns on therapeutic proteins to improve their efficacy and safety.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.